Clinical Spectrum of Juvenile Idiopathic Arthritis in Children in Tertiary Care Hospital
Clinical Spectrum of Juvenile Idiopathic Arthritis in Children
DOI:
https://doi.org/10.36283/PJMD13-3/004Keywords:
treatment outcomes, heterogeneity, clinical characteristics, rheumatoid factor, Juvenile arthritisAbstract
Background: Juvenile idiopathic arthritis (JIA) an autoimmune illness affects infants and teenagers worldwide. The study aimed to find the clinical, laboratory, therapeutic, and demographic characteristics associated with JIA patients in a tertiary care hospital.
Methods: This retrospective cross-sectional study examined the clinical spectrum of JIA in children at Khyber Teaching Hospital, Peshawar from February 25 to August 25, 2023. A total of 106 patients of both genders of less than 16 years of age, who fulfilled the International League of Association for Rheumatology (ILAR) criteria for JIA, were enrolled through the convenience sampling technique in this study. Diagnostic assessments, including clinical evaluations, laboratory testing, and imaging examinations were documented. Data analysis performed by SPSS 16.
Results: Out of the total patients (n=102), 61.8% were male with mean age at presentation being 9.44±3.89 years (2-7 years) and median duration of disease being 24 months (interquartile range 42 months). The majority (n=55, 53.9%) fall in the 11-15 age group, with Polyarticular RF Negative JIA prevailing 45 (44.1%, p<0.001%). Enthesial pain is frequent (n=84, 82.4%), while fever (n=47, 46.1% p=0.176) and lower back pain (n=35, 34.3%) were noted. Rashes were infrequent (n=10, 9.8%), and most reported symptoms for over 36 months (n=55, 53.9%). Treatment involves predominantly methotrexate (n=77, 75.5%). Gender and subtype disparities emphasize the intricate heterogeneity in symptom manifestation (p<0.05).
Conclusion: The study findings have shown that the JIA is significantly associated with clinical, laboratory, and demographic factors and suggests crafting a policy for on-time diagnosis and management of JIA.
Keywords: Autoimmune Diseases, Juvenile Arthritis, Rheumatoid Factor.
References
Al-Mayouf SM, Al Mutairi M, Bouayed K, Habjoka S, Hadef D, Lotfy HM, et al. Epidemiology and demographics of juvenile idiopathic arthritis in Africa and the Middle East. Pediatric Rheumatology. 2021;19(1):166. https://doi.org/10.1186/s12969-021-00650-x
Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, et al. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol. 2013;40(7):1218-1225. DOI: 10.3899/jrheum.120661
Horneff G, Borchert J, Heinrich R, Kock S, Klaus P, Dally H, et al. Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study. Pediatric Rheumatology. 2022;20(1):100. DOI: 10.1186/s12969-022-00755-x
Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint but also the heart. Clinical Rheumatology. 2023;42(10):2703-2715. DOI: 10.1007/s10067-023-06621-9
Sur LM, Gaga R, Duca E, Sur G, Lupan I, Sur D, et al. Different Chronic Disorders That Fall within the Term Juvenile Idiopathic Arthritis. Life (Basel). 2021;11(5). DOI: 10.3390/life11050398
Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J. 2021;19(1):135. DOI: 10.1186/s12969-021-00629-8
Alberto M, Angelo R, Tadej A, Michael WB, Ruben B-V, Ruben C, et al. Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. The Journal of Rheumatology. 2019;46(2):190. DOI: https://doi.org/10.3899/jrheum.180168
Eng SW, Duong TT, Rosenberg AM, Morris Q, Yeung RS. The biologic basis of clinical heterogeneity in juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66(12):3463-3475. DOI: 10.1002/art.38875
Bano S, Bosan K, Khurshid S, Rasheed U, Zeb A, Zammurrad S. Prevalence of Depression in Patients with Juvenile Idiopathic Arthritis Presenting at a Tertiary Care Hospital. Cureus. 2020;12(1):e6807. Doi: 10.7759/cureus.6807
Aslam J, Zaman H, Ubaid M. Reactive Protein can be used as a Diagnostic Tool for Acute Appendicitis. National Journal of Life and Health Sciences. 2022;1(1):13-15. DOI: https://doi.org/10.62746/njlhs.v1n1.7
Dave M, Rankin J, Pearce M, Foster HE. Global prevalence estimates of three chronic musculoskeletal conditions: club foot, juvenile idiopathic arthritis and juvenile systemic lupus erythematosus. Pediatric Rheumatology. 2020;18(1):49. DOI: https://doi.org/10.1186/s12969-020-00443-8
Singh A, Masuku M. Sampling Techniques and Determination of Sample Size in Applied Statistics Research: An Overview. International Journal of Commerce and Management. 2014;2:1-22. https://www.ijecm.co.uk/wp-content/uploads/2014/11/21131.pdf
Ben Tekaya A, Hannech E, Saidane O, Rouached L, Bouden S, Tekaya R, et al. Association between Rheumatic Disease Comorbidity Index and factors of poor prognosis in a cohort of 280 patients with rheumatoid arthritis. BMC Rheumatol. 2022;6(1):78. Doi: 10.1186/s41927-022-00308-5
Kunjir V, Venugopalan A, Chopra A. Profile of Indian Patients with Juvenile Onset Chronic Inflammatory Joint Disease Using the ILAR Classification Criteria for JIA: A Community-based Cohort Study. The Journal of Rheumatology. 2010;37(8):1756. DOI: 10.3899/jrheum.090937
Lin C-H, Lin C-L, Shen T-C, Wei C-C. Epidemiology and risk of juvenile idiopathic arthritis among children with allergic diseases: a nationwide population-based study. Pediatric Rheumatology. 2016;14(1):15. DOI: 10.1186/s12969-016-0074-8
Shih YJ, Yang YH, Lin CY, Chang CL, Chiang BL. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease. Pediatr Rheumatol Online J. 2019;17(1):58. DOI: 10.1186/s12969-019-0363-0
Hardal C, Erguven M, Saglam ZA. Systemic juvenile idiopathic arthritis as a fever of unknown origin. North Clin Istanb. 2017;4(1):81-84. Doi: 10.14744/nci.2016.07769
Golhen K, Winskill C, Yeh C, Zhang N, Welzel T, Pfister M. Value of Literature Review to Inform Development and Use of Biologics in Juvenile Idiopathic Arthritis. Frontiers in Pediatrics. 2022;10. DOI: 10.3389/fped.2022.909118
Zaripova LN, Midgley A, Christmas SE, Beresford MW, Baildam EM, Oldershaw RA. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatric Rheumatology. 2021;19(1):135. DOI: 10.1186/s12969-021-00629-8
Mussadiq S, Verma RK, Singh DP, Bajpai PK, Begum N, Kumar S. An epidemiological study and trend analysis of laboratory confirmed COVID-19 cases among children in North India. J Family Med Prim Care. 2022;11(2):542-546. DOI: 10.4103/jfmpc.jfmpc_1239_21
Green MS, Schwartz N, Peer V. A meta-analytic evaluation of sex differences in meningococcal disease incidence rates in 10 countries. Epidemiol Infect. 2020;148:e246. DOI: 10.1017/S0950268820002356
Oberle EJ, Harris JG, Verbsky JW. Polyarticular juvenile idiopathic arthritis - epidemiology and management approaches. Clin Epidemiol. 2014;6:379-393. Doi: 10.2147/CLEP.S53168
Feger DM, Longson N, Dodanwala H, Ostrov BE, Olsen NJ, June RR. Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use. J Clin Rheumatol. 2019;25(4):163-170. DOI: 10.1097/RHU.0000000000000819
Walsh JA, Magrey M. Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. J Clin Rheumatol. 2021;27(8):e547-e60. DOI: 10.1097/RHU.0000000000001575
Bentaleb I, Abdelghani KB, Rostom S, Amine B, Laatar A, Bahiri R. Reactive Arthritis: Update. Current Clinical Microbiology Reports. 2020;7(4):124-132. DOI: https://doi.org/10.1007/s40588-020-00152-6
Şener G, İnan Yuksel E, Gökdeniz O, Karaman K, Canat HD. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis. Cureus. 2023;15(8):e43790. DOI: 10.7759/cureus.43790
Murakami J, Shimizu Y. Hepatic manifestations in hematological disorders. Int J Hepatol. 2013;2013:484903. DOI: 10.1155/2013/484903
Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019;86(3):301-307. Doi: 10.1016/j.jbspin.2018.07.004
Harris JG, Kessler EA, Verbsky JW. Update on the treatment of juvenile idiopathic arthritis. Curr Allergy Asthma Rep. 2013;13(4):337-346. Doi: 10.1007/s11882-013-0351-2
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
How to Cite
